PBH Strangle Strategy
PBH (Prestige Consumer Healthcare Inc.), in the Healthcare sector, (Medical - Distribution industry), listed on NYSE.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018.
PBH (Prestige Consumer Healthcare Inc.) trades in the Healthcare sector, specifically Medical - Distribution, with a market capitalization of approximately $2.45B, a trailing P/E of 12.88, a beta of 0.40 versus the broader market, a 52-week range of 49.28-89.37, average daily share volume of 521K, a public-listing history dating back to 2005, approximately 600 full-time employees. These structural characteristics shape how PBH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.40 indicates PBH has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a strangle on PBH?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current PBH snapshot
As of May 15, 2026, spot at $46.94, ATM IV 24.30%, IV rank 7.96%, expected move 6.97%. The strangle on PBH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on PBH specifically: PBH IV at 24.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a PBH strangle, with a market-implied 1-standard-deviation move of approximately 6.97% (roughly $3.27 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PBH expiries trade a higher absolute premium for lower per-day decay. Position sizing on PBH should anchor to the underlying notional of $46.94 per share and to the trader's directional view on PBH stock.
PBH strangle setup
The PBH strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PBH near $46.94, the first option leg uses a $49.29 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PBH chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PBH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $49.29 | N/A |
| Buy 1 | Put | $44.59 | N/A |
PBH strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
PBH strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on PBH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on PBH
Strangles on PBH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PBH chain.
PBH thesis for this strangle
The market-implied 1-standard-deviation range for PBH extends from approximately $43.67 on the downside to $50.21 on the upside. A PBH long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current PBH IV rank near 7.96% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PBH at 24.30%. As a Healthcare name, PBH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PBH-specific events.
PBH strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PBH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PBH alongside the broader basket even when PBH-specific fundamentals are unchanged. Always rebuild the position from current PBH chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on PBH?
- A strangle on PBH is the strangle strategy applied to PBH (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With PBH stock trading near $46.94, the strikes shown on this page are snapped to the nearest listed PBH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PBH strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PBH strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 24.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PBH strangle?
- The breakeven for the PBH strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PBH market-implied 1-standard-deviation expected move is approximately 6.97%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on PBH?
- Strangles on PBH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PBH chain.
- How does current PBH implied volatility affect this strangle?
- PBH ATM IV is at 24.30% with IV rank near 7.96%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.